Denggang Fu

Denggang Fu

Medical University of South Carolina

H-index: 10

North America-United States

About Denggang Fu

Denggang Fu, With an exceptional h-index of 10 and a recent h-index of 10 (since 2020), a distinguished researcher at Medical University of South Carolina, specializes in the field of Cancer Immunity, Bioinformatics, Leukemia, Tumor Immunotherapy, Stem Cell.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature

Analysis of screening outcomes and factors influencing compliance among community-based lung cancer high-risk population in Nanchang, China, 2018-2020

Early Prognostic Biomarkers of Non-Relapse Mortality in Allogeneic Mismatched Unrelated Hematopoietic Cell Transplantation

Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy

Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl) pyrrole-Based Stimulation-2 (ST2) Inhibitors

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death

Hepatoprotective potential of Anagallis arvensis (L.) extract against carbon tetrachloride (CCl4)-induced hepatic injury and oxidative stress in rabbits.

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment

Denggang Fu Information

University

Position

___

Citations(all)

315

Citations(since 2020)

295

Cited By

76

hIndex(all)

10

hIndex(since 2020)

10

i10Index(all)

11

i10Index(since 2020)

11

Email

University Profile Page

Google Scholar

Denggang Fu Skills & Research Interests

Cancer Immunity

Bioinformatics

Leukemia

Tumor Immunotherapy

Stem Cell

Top articles of Denggang Fu

Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature

Heliyon

2024/3/30

Denggang Fu
Denggang Fu

H-Index: 5

Analysis of screening outcomes and factors influencing compliance among community-based lung cancer high-risk population in Nanchang, China, 2018-2020

Frontiers in Oncology

2024

Early Prognostic Biomarkers of Non-Relapse Mortality in Allogeneic Mismatched Unrelated Hematopoietic Cell Transplantation

Blood

2023/11/28

Immunogenomic classification of lung squamous cell carcinoma characterizes tumor immune microenvironment and predicts cancer therapy

Genes & Diseases

2023/11/1

Denggang Fu
Denggang Fu

H-Index: 5

Hua Jiang
Hua Jiang

H-Index: 39

Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl) pyrrole-Based Stimulation-2 (ST2) Inhibitors

ACS Pharmacology & Translational Science

2023/8/16

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death

Journal of Clinical Investigation

2023/8/1

Hepatoprotective potential of Anagallis arvensis (L.) extract against carbon tetrachloride (CCl4)-induced hepatic injury and oxidative stress in rabbits.

Pakistan Journal of Pharmaceutical Sciences

2023/7/1

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment

Frontiers in Cell and Developmental Biology

2023

Novel Chemical Series of Anti-ST2 Small Molecules Suppress Allogeneic T Cells Proliferation While Increasing Treg Cells and Improve Gvhd and Survival In Vivo

Blood

2022/11/15

Single Cell Analysis Identifies Immune Marker IL4I1 As Critical for Leukemogenesis and Immunity

Blood

2022/11/15

Current definitions and clinical implications of biomarkers in graft-versus-host disease

2022/10/1

Structure-Activity relationship of 1-(Furan-2ylmethyl) Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease

Bioorganic & medicinal chemistry

2022/10/1

Characterization of Tumor Immune Microenvironment and Cancer Therapy For Head and Neck Squamous Cell Carcinoma Through Identification of A Genomic Instability-Related LncRNA …

Frontiers in Genetics

2022

Denggang Fu
Denggang Fu

H-Index: 5

Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses

Gene

2021/1/5

Immunotherapy Targeting ST2/IL-33 Signaling in Myeloid Leukemia Stem Cells

Blood

2021/11/23

T cell subsets in graft versus host disease and graft versus tumor

2021/10/5

Identification of survival-related alternative splicing signatures in acute myeloid leukemia

Bioscience Reports

2021/7

Prognosis and characterization of immune microenvironment in acute myeloid leukemia through identification of an autophagy-related signature

Frontiers in Immunology

2021/5/31

Development of an immune-related risk signature for predicting prognosis in lung squamous cell carcinoma

Frontiers in Genetics

2020/8/28

Denggang Fu
Denggang Fu

H-Index: 5

Lei Yang
Lei Yang

H-Index: 4

miR-431 regulates granulosa cell function through the IRS2/PI3K/AKT signaling pathway

Journal of Reproduction and Development

2020

See List of Professors in Denggang Fu University(Medical University of South Carolina)